ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Trading setups for next week

 

( click to enlarge )
Camber Energy Inc (NYSEAMERICAN:CEI) stock has been pulling back quite a bit in the past few days but nothing is wrong with it, the uptrend remains intact and pullbacks are always healthy for a trend continuation. Seems to be forming an uptrend channel on hourly chart  with a major support at 2.50 with a minor support at 2.86. Plus, it has been under accumulation in a quiet manner. So, play what you see.
( click to enlarge )
Indaptus Therapeutics, Inc. (INDP) is setting up for a possible breakout, which based on the chart could send the stock up like a rocket. The RSI14 at 40 and the MACD is still curling upward. Chart on Breakout Watch.
( click to enlarge )
LM Funding America, Inc. (LMFA) had good volume and a big bullish candlestick on Friday. Breakout watch over 4.98
( click to enlarge )
CASI Pharmaceuticals, Inc. (CASI) is still in bottoming mode. The technical indicators are looking better now for the stock. The MACD is starting to rise, confirming a bullish divergence has taken form and the Stochastic also has a bullish crossover. It might attempt to breakout above the $1.25 level on Monday and if it succeeds we should expect a strong move to the upside. It has the potential to make another big run next week, so keep a close eye on CASI and don’t miss the trade. The price target of the two Wall Street analysts that rated the stock since the last quarterly report is $3.9
( click to enlarge )
I want to congratulate anyone that saw the opportunity in Silverback Therapeutics, Inc. (SBTX) at $10. Keep watch because the technicals are indicating there could be more juice left in this small bio cap, offering up multiple intraday entry points. Real fireworks begin over 12
( click to enlarge )
Sphere 3D Corp. (ANY) We have all seen how quickly this stock can head higher, when the buyers come. Watch this BOX and play accordingly. I believe it is ready to post a nice bounce and I do not see any resistance on the technical chart until $7.6. From a technical standpoint, the Relative Strength Index is now rising and is approaching the mid-level, while MACD is about to cross up.
( click to enlarge )
Chemomab Therapeutics Ltd (NASDAQ:CMMB) My opinion remains intact about this small bio cap. I will not sell a single share below $40 unless something bad happens, but that does not seem to be the case according to the recent news and reports. The stock has been falling on very low volume. The company has a great pipeline and the existing cash position is expected to fund the Company's current operating plan until mid 2023. The stock market is a device for transferring money from the impatient to the patient" Warren Buffet. I remember being called a pumper on PLUG or MARA when the stocks were trading at $2. NOTE: The 2 Wall Street analysts offering 12-month price forecasts for Chemomab Therapeutics Ltd have a median target of 43.50, with a high estimate of 45.00 and a low estimate of 42.00
( click to enlarge )
AMC Entertainment Holdings Inc (NYSE:AMC) Rallied nicely Thursday on volume and broke out of a descending channel. If it clears back over 42, it may have some good upside.
( click to enlarge )
Pedevco Corp (NYSEAMERICAN:PED) broke out of a consolidation range to the upside on heavy volume. I do not see anything until the 2.8-3 area. Indicators are also showing signs of recovery. Pullbacks are buyable.
( click to enlarge )
ENGlobal Corp (NASDAQ:ENG) is very bullish with a lot of hot indicators showing up. The slope of the upward move is steep accompanied by increasing volume. Breakout watch over 3.37
TRADE IDEAS TEST DRIVE IS BACK: The next 2-week Test Drive starts October 11, and runs until October 22nd. The Test Drive lets non-subscribers or standard subscribers enjoy all Premium Subscription features for up to 2-weeks. I recommend you sign up HERE before Monday, October 11 so you will have the full 2-weeks of access.
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

AC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.